G. Pantaleo

Discipline

Histoire, Philosophie et Sociologie des sciences (4) Psychologie (2) Sciences de l'information et de la communication (2) Economies et finances (2) Sociologie (1) Anthropologie biologique (1)

Type de document

Articles (84) Recensions (4)

Co-auteur

Date

Source

Mot-clé

Human beings (48) virus (37) Infection (37) infection (36) Treatment (32) T cells (31) Cells (28) Patients (27) Patients (27) protéine (22) Control (22) Therapeutics (22) Immunoglobulins (22) thérapie (21) anticorps (20) Expression (20) maladie (19) immunité (18) maladie (18) adulte (18) Immunodeficiency (18) Immunity (18) Blood (18) adulte (18) procès (16) cohorte (16) Cytokines (15) Older people (15) spectacle (13) Vaccination (13)

Documents écrit par G. Pantaleo (84) | parle de G. Pantaleo (0)

Development of hybrid immunity during a period of high incidence of Omicron infections.
A. Frei et al. (25 déc. 2023)
Association of plasma zinc levels with anti-SARS-CoV-2 IgG and IgA seropositivity in the general population: A case-control study.
S. Gonseth-Nusslé et al. (18 avr. 2023)
A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells.
V. Joo et al. (2023)
SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection.
D. Jacot et al. (2023)
Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial.
G. Stalder et al. (1 janv. 2023)
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
I.T. Schrijver et al.
Antibodies to combat viral infections: development strategies and progress.
G. Pantaleo et al.
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
F.R. Girardin et al. (23 mai 2022)
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
A. Kritikos et al. (18 mai 2022)
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients.
M. Obeid et al. (1 mai 2022)
High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
J. Herderschee et al.
A highly potent antibody effective against SARS-CoV-2 variants of concern.
C. Pellaton et al. (12 oct. 2021)
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
M. Perreau et al. (9 août 2021)
Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.
H. Chehade et al. (31 juil. 2021)
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
G. Guzzo et al. (6 juil. 2021)
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
S. Meylan et al. (5 juil. 2021)
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
R. Bernard-Valnet et al.
In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging.
K. Ioannidou et al. (28 févr. 2021)
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
C. André et al. (13 janv. 2021)
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
G. Guzzo et al. (2021)
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
P. Filippidis et al. (2021)
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.
M. Giel-Moloney et al. (27 déc. 2019)
Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway.
C. Fenwick et al. (1 juil. 2019)
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement.
R. Banga et al.
Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1).
A. Mancarella et al.

next